Kenneth Algazy
Clinical Professor of Medicine
Department: Medicine
Contact information
Perelman Center 2nd Floor West
and Phila. VAMC 8A120
Philadelphia, PA 19104
and Phila. VAMC 8A120
Philadelphia, PA 19104
Office: 215-615-5810
Fax: 215-615-5888
Fax: 215-615-5888
Education:
BS
Villanova University, 1965.
MD
Temple University School of Medicine, 1969.
BS
Villanova University, 1965.
MD
Temple University School of Medicine, 1969.
Post-Graduate Training
Intern in Medicine, Abington Memorial Hospital, Abington, PA, 1969-1970.
Resident in Medicine, Strong Memorial Hospital, Rochester, NY, 1970-1972.
Fellowship, Hematology, Johns Hopkins University Hospital, Baltimore, MD, 1972-1974.
Intern in Medicine, Abington Memorial Hospital, Abington, PA, 1969-1970.
Resident in Medicine, Strong Memorial Hospital, Rochester, NY, 1970-1972.
Fellowship, Hematology, Johns Hopkins University Hospital, Baltimore, MD, 1972-1974.
Certifications
National Board of Medical Examiners, 1970.
American Board of Internal Medicine, 1972.
ABIM, Hematology, 1974.
ABIM, Oncology, 1979.
Permanent linkNational Board of Medical Examiners, 1970.
American Board of Internal Medicine, 1972.
ABIM, Hematology, 1974.
ABIM, Oncology, 1979.
Description of Clinical Expertise
Lung cancerSelected Publications
Chapters: Idiopathic Thrombocytopenic Purpura, Polycythemia Vera, Thrombocytosis, Cold Induced Hemolysis. NORD Guide to Rare Diseases. Lippincott Williams and Wilkins, Philadelphia, Pennsylvania, 2003.Review: EBV Associated Severe Thrombocytopenia. Resident & Staff Physician March 2003.
Campling, B.G., Hwang, W-T., Zhang, J., Thompson, S., Vachani, A., Rosen, I.M., K.M.Algazy: The University of Pennsylvania School of Medicine And the Philadelphia VA Medical Center, Philadelphia , Pa: Population Based Study of Lung Cancer in Penna.: Comparison of VA and Civilian Populations. Cancer May 2003.
Stevenson, J., Nho, C.W., Schick, J., Johnson, S.W., Algazy, K., Miller, D., & P.J.Odwyer: Phase II Clinical/pharmacodynamic Trial of the Proteosome Inhibitor PS341 In Advanced Non-Small Cell Lung Cancer. ASCO May 2003.
Bilenker, J.H., Rosen, M.A., Gallagher, M.A., Stevenson, J.P., Flaherty, K.T., Algazy, K.M., Sun, W., Schnall, M., & P.J.Odwyer: Phase 1b Trial of Combretastatin in Combination with Carboplatin in Patients with Advanced cancer. ASCO May 2003.
Campbell A., Campling B., Algazy KM., El-Diery, W: Bedside-to-Bench Report: Clinical and molecular features of small cell carcinoma of the lung. Cancer Biology and Therapy 1/2: 105-112, March/April 2002.
Algazy, K: Letter to the Editor; Spinner’s Hematuria. New England Journal of Medicine 346(21): 1676, 2002.
Rosenthal DI., Yom SS., Liu L., Machtay M., Algazy KM., Weber RS., Weinstein GS., Chalian AA., Miller LK., Rockwell K., Tonda M., Schnipper E., Hershock D: A Phase I study of SPI-77 (Stealth Liposomal Cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer. Investigational New Drugs 20: 343-349, 2002 Notes: accepted.
Stevenson, JP,Sun, W., Gallagher, M., Johnson, R., Vaugn, D. Schuchter, L., Algazy,K. et. Al: Phase I Trial of Cryptophysin Analogue Ly355703. Clin Cancer Res Page: 2524-2529, August 2002.
Sun, W.,Stevenson, J.P., Gallo, J.M., Redlinger, M., Haller, D., Algazy, K., Giantonio, B., Alila, H., Odwyer, P.J: Phase I and Pharmacokinetic Trial of a ProapoptoticSulindac Analogue CP-461 in Patients with Advanced Cancer Clin. Cancer, Res 8(10): 3100-3104, Oct 2002.